https://corporate.abcam.com/wp-content/uploads/2021/02/AH_Feature_Logo.png
245
350
connective
/wp-content/uploads/2020/07/logo.png
connective2021-02-09 07:00:582021-02-08 20:01:37Abingdon Health signs collaboration and co-marketing agreement with Abcam
https://corporate.abcam.com/wp-content/uploads/2021/01/EcoVadis-PN.jpg
350
500
Pierre Peotta
/wp-content/uploads/2020/07/logo.png
Pierre Peotta2021-01-25 09:00:042021-01-27 09:03:32Abcam Partners with EcoVadis to Support Sustainability across its Supply Chain
https://corporate.abcam.com/wp-content/uploads/2021/01/Glassdoor-PN-2.jpg
350
500
Pierre Peotta
/wp-content/uploads/2020/07/logo.png
Pierre Peotta2021-01-13 08:28:362021-02-03 13:28:45Abcam Recognized as UK’s 3rd Best Place to Work in 2021 by Glassdoor
https://corporate.abcam.com/wp-content/uploads/2021/01/Flags-PN.jpg
350
500
Pierre Peotta
/wp-content/uploads/2020/07/logo.png
Pierre Peotta2021-01-11 15:18:342021-02-03 13:28:41Abcam – Half Year Trading Update
https://corporate.abcam.com/wp-content/uploads/2021/01/Feature-image.jpg
350
500
Pierre Peotta
/wp-content/uploads/2020/07/logo.png
Pierre Peotta2021-01-07 09:51:292021-02-03 13:28:35Abcam and Shuwen extend strategic alliance in China to develop companion diagnostics
https://corporate.abcam.com/wp-content/uploads/2020/12/GCI-2-PN1.jpg
350
500
Pierre Peotta
/wp-content/uploads/2020/07/logo.png
Pierre Peotta2020-12-08 11:05:102020-12-08 11:58:24Abcam reveals new cell engineering facility in Bay Area
https://corporate.abcam.com/wp-content/uploads/2020/11/Prot-NPA-PR-PN.png
245
350
Pierre Peotta
/wp-content/uploads/2020/07/logo.png
Pierre Peotta2020-11-03 08:00:132020-12-01 14:57:34Abcam’s new premium-grade bioactive proteins, for drug discovery, development and manufacturing
https://corporate.abcam.com/wp-content/uploads/2020/10/BIA-Covid-PR-PN.jpg
245
350
Pierre Peotta
/wp-content/uploads/2020/07/logo.png
Pierre Peotta2020-10-29 08:00:502020-11-20 12:36:59Novel COVID-19 Antibody Therapy Candidates Identified by Leading UK Biotech Consortium
https://corporate.abcam.com/wp-content/uploads/2020/10/Abcam-Tower-Pn.jpg
245
350
James Staveley
/wp-content/uploads/2020/07/logo.png
James Staveley2020-10-22 07:00:452020-11-20 12:40:05Abcam Announces Pricing of Offering on NASDAQ
https://corporate.abcam.com/wp-content/uploads/2020/09/abcam-grey-PR-PN-2.png
245
350
James Staveley
/wp-content/uploads/2020/07/logo.png
James Staveley2020-09-14 07:00:422020-11-04 21:33:25Abcam announces Full Year results
https://corporate.abcam.com/wp-content/uploads/2020/03/Partnership_News.png
245
350
connective
/wp-content/uploads/2020/07/logo.png
connective2020-07-07 09:00:082020-12-04 10:41:18Cancer Research UK and Abcam launch custom partnership to accelerate cancer researchWe are empowering the global life science and clinical communities. Delivering the next generation tools and solutions that are helping accelerate research, leading to new discoveries with positive impact on society.
Discovery Drive, Cambridge
Biomedical Campus,
Cambridge, CB2 0AX, UK
+44 (0) 1223 696 000
© Abcam plc. all rights reserved.
Abcam plc is incorporated in England and Wales, its main country of operation in the UK. Use of this website is subject to our Terms and Conditions of use and our Privacy Policy. Share price and news information on this site is updated dynamically from external data feeds. Static content was last updated on 09 Nov 2020.
Website by FisherPaul
